Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)

Q3 2021 13F Holders as of 9/30/2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Number of holders: 56
Total Shares: 28.2M
Shares change: +4.46M
Total reported value, excl. options: $136M
Value change: +$22.8M
Put/Call ratio: 0.46
Number of buys: 30
Number of sells: -26
Price: $4.84

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.